4525 - Pancreatic Cancer: Research (Answered)

Stuart Andrew
To ask the Secretary of State for Health, what steps he is taking to increase the quality and quantity of research into pancreatic cancer.

George Freeman

My Rt. hon. Friend the Secretary of State for Health has had no such discussions.

Expenditure by the Department’s National Institute for Health Research (NIHR) on cancer research is shown in the following table.

£ million

2010/11

2011/12

2012/13

2013/14

4475 - Ovarian Cancer: Health Services (Answered)

Ms Margaret Ritchie
To ask the Secretary of State for Health, what assessment he has made of the potential cost and benefits of advanced genetic testing techniques for the clinical assessment and treatment of ovarian cancer; and if he will make a statement.

George Freeman

The Department is directly supporting the adoption of emerging genetic testing techniques through the 100,000 Genomes Project. The initiative includes the analysis of the genomic changes seen in ovarian cancer and how these are related to clinical outcomes.

3758 - Malaria: Drugs (Answered)

Jim Shannon
To ask the Secretary of State for Health, what estimate he has made of the likely timescale for making the new compound for the treatment of malaria discovered at Durham University available on the NHS.

George Freeman

The Department is not aware of any such compound being discovered at Durham University for malaria treatment.

3748 - Drugs: Misuse (Answered)

Jim Shannon
To ask the Secretary of State for Health, what steps he is taking to reduce the use of non-prescribed medication.

George Freeman

With proper support from health professionals, such as pharmacists and general practitioners, non-prescribed medicines like Pharmacy (P) or General Sale List (GSL) medicines available ‘over the counter’ play a significant role in helping people take more responsibility for their own health.

3746 - Prescription Drugs: Costs (Answered)

Jim Shannon
To ask the Secretary of State for Health, what discussions he has had with (a) university research and development departments and (b) pharmaceuticals companies on reducing the cost of NHS-prescribed medicines.

George Freeman

Regular discussions take place with a full range of stakeholders concerning both the pricing of branded medicines and accelerating patient access to innovative medicines.

3757 - Bacterial Diseases: Drugs (Answered)

Jim Shannon
To ask the Secretary of State for Health, what estimate he has made of the likely timescale for making new drugs available on the NHS to treat Klebsiella infections.

George Freeman

We have made no such estimate.

3756 - Cancer: Drugs (Answered)

Jim Shannon
To ask the Secretary of State for Health, what steps he is taking to ensure that appropriate cancer drugs are prescribed for cancer patients with diabetes and that the use of inappropriate drugs for such patients is eliminated.

George Freeman

Appropriate drugs for the treatment of cancer should be prescribed as part of a wider pathway of care coordinated by a multidisciplinary team. This should include specialists in other relevant long term conditions such as diabetes.

3431 - Patient Choice Schemes (Answered)

Dr Matthew Offord
To ask the Secretary of State for Health, what steps his Department is taking to promote the use of the Choose and Book system.

George Freeman

The NHS e-Referral Service replaced the previous electronic system, Choose and Book, on 15 June 2015.

3821 - Hearing Impairment (Answered)

Ruth Smeeth
To ask the Secretary of State for Health, when he expects NICE to publish the (a) clinical guidance and (b) quality standard for adult onset hearing loss.

George Freeman

The National Institute for Health and Care Excellence has advised that the clinical guideline on hearing loss is currently scheduled for development from spring 2016 and anticipates that this will be published in autumn 2018. A quality standard on hearing loss based on the clinical guideline will follow.

3814 - Cancer: Drugs (Answered)

Mark Tami
To ask the Secretary of State for Health, when the Cancer Drugs Fund panel will next meet to discuss the appraisal of new medicines.

George Freeman

NHS England has advised that the Cancer Drugs Fund panel expects to meet next on 29 and 30 July 2015.

Pages